S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

NantHealth (NASDAQ:NH) Upgraded to "Buy" by Zacks Investment Research

Thursday, January 14, 2021 | MarketBeat

NantHealth (NASDAQ:NH) was upgraded by Zacks Investment Research from a "hold" rating to a "buy" rating in a research note issued on Thursday, Zacks.com reports. The firm presently has a $4.00 target price on the stock. Zacks Investment Research's target price points to a potential upside of 17.99% from the stock's current price.

According to Zacks, "Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets of molecular, clinical, operational and financial data points derived from novel and traditional sources. Nant Health, LLC is based in CULVER CITY, United States. "

A number of other research analysts also recently weighed in on NH. BidaskClub raised NantHealth from a "strong sell" rating to a "sell" rating in a research note on Saturday, December 12th. ValuEngine downgraded NantHealth from a "buy" rating to a "hold" rating in a research note on Monday, November 2nd.

Shares of NASDAQ:NH opened at $3.39 on Thursday. The company has a market capitalization of $377.02 million, a price-to-earnings ratio of -7.70 and a beta of 1.75. The business's 50-day moving average is $3.03 and its 200-day moving average is $3.16. NantHealth has a 1 year low of $1.10 and a 1 year high of $6.60.

NantHealth (NASDAQ:NH) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.08) by $0.01. The business had revenue of $18.77 million during the quarter, compared to analyst estimates of $18.70 million. Research analysts predict that NantHealth will post -0.31 EPS for the current fiscal year.

A number of hedge funds have recently bought and sold shares of the stock. AQR Capital Management LLC bought a new stake in NantHealth during the 3rd quarter worth approximately $867,000. Arrowstreet Capital Limited Partnership bought a new stake in NantHealth during the 3rd quarter worth approximately $616,000. Morgan Stanley increased its holdings in NantHealth by 726.4% during the 3rd quarter. Morgan Stanley now owns 113,744 shares of the company's stock worth $266,000 after purchasing an additional 99,981 shares in the last quarter. Nuveen Asset Management LLC bought a new stake in NantHealth during the 2nd quarter worth approximately $436,000. Finally, Bank of New York Mellon Corp bought a new stake in NantHealth during the 2nd quarter worth approximately $337,000. 4.76% of the stock is currently owned by institutional investors and hedge funds.

About NantHealth

NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company converging science and technology in the United States, the United Kingdom, Singapore, and Canada. It provides NantHealth solutions, including molecular profiling solutions, software-as-a-service platforms, and connected care medical device interoperability solutions to enable value-based care and evidence-based clinical practice.

See Also: How is the discount rate different from the Federal Funds rate?

Get a free copy of the Zacks research report on NantHealth (NH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]


7 Things You Need To Know About Cryptocurrency

The Cryptocurrency Market Is About To Boil Over

The cryptocurrency was quiet for years, but it’s starting to boil over once again. With the price of Bitcoin up 550%, it certainly seems like the sky is the limit.

Whether or not you choose to trade Bitcoin or any other cryptocurrency, it is important to understand what it is and the trends driving it.

The bottom line, however, is that the world’s money is flowing onto the blockchain, and the use of cryptocurrency is growing at an exponential rate.

View the "7 Things You Need To Know About Cryptocurrency".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.